Bristol-Myers Squibb to Take Part in Citi 2018 Global Healthcare Conference
NEW YORK--(BUSINESS WIRE)--Nov 29, 2018--Bristol-Myers Squibb Company (NYSE:BMY) will take part in the Citi 2018 Global Healthcare Conference on Thursday, December 6, 2018 in New York. Tom Lynch, chief scientific officer, will answer questions about the company at 2:10 p.m. ET.
Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.
View source version on businesswire.com:https://www.businesswire.com/news/home/20181129005019/en/
CONTACT: Media:Carrie Fernandez, 609-252-5222,firstname.lastname@example.org
Investors: Tim Power, 609-252-7509,email@example.com Bill Szablewski,
KEYWORD: UNITED STATES NORTH AMERICA NEW YORK
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CLINICAL TRIALS PHARMACEUTICAL
SOURCE: Bristol-Myers Squibb Company
Copyright Business Wire 2018.
PUB: 11/29/2018 06:59 AM/DISC: 11/29/2018 06:59 AM